...
首页> 外文期刊>AJRI: American Journal of Reproductive Immunology >Relationship between cytokine concentrations (FGF, sICAM-1 and SCF) in serum, follicular fluid and ICSI outcome.
【24h】

Relationship between cytokine concentrations (FGF, sICAM-1 and SCF) in serum, follicular fluid and ICSI outcome.

机译:血清,卵泡液中细胞因子浓度(FGF,sICAM-1和SCF)与ICSI结果之间的关系。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: The aim of this study was (i) to investigate the existence of fibroblast growth factor (FGF), soluble intracellular adhesion molecule-1 (sICAM-1), and stem cell factor (SCF) in serum and human follicular fluid (FF) of intracytoplasmic sperm injection (ICSI) patients, and (ii) to determine the relationship between these parameters and ICSI outcome. MATERIAL AND METHOD: Seventy-five patients undergoing controlled ovarian hyperstimulation with human menopausal gonadotropin (hMG) after down-regulation with GnRHa were included in this study. The concentrations of FGF, SCF, and sICAM-1 were measured by using commercially available enzyme-linked immunosorbent assay test kits. RESULTS: The FGF, sICAM-1, and SCF concentrations in the serum of women who become pregnant (group I) were 8.5 +/- 1.5 pg/mL, 235.8 +/- 81.1 ng/mL, and 597.7 +/- 139.9 pg/mL, and the corresponding concentrations of women who did not (group II) were 6.4 +/- 3.6 pg/mL, 230.6 +/- 66.5 ng/mL, and 569.6 +/- 91.4 pg/mL respectively.No significant difference was observed between the two investigated groups with regard to the number of hMG ampoules administered for controlled ovarian hyperstimulation, estradiol concentration on the day of human chorionic gonadotropin (hCG) injection, number of retrieved oocytes and fertilization rate. CONCLUSION: The concentration of FGF, sICAM-1, and SCF did not differ significantly between the two groups in serum or in FF. Besides, the ICSI outcome was not related to their concentrations in serum or FF. Therefore, these parameters could not be used as a prognostic factor in ICSI program.
机译:目的:(i)研究血清和人卵泡液(FF)中成纤维细胞生长因子(FGF),可溶性细胞内粘附分子1(sICAM-1)和干细胞因子(SCF)的存在)胞浆内精子注射(ICSI)患者,以及(ii)确定这些参数与ICSI结果之间的关系。材料与方法:75例患者在GnRHa下调后接受了人类更年期促性腺激素(hMG)控制性卵巢过度刺激。 FGF,SCF和sICAM-1的浓度是通过使用可商购的酶联免疫吸附法检测试剂盒测得的。结果:怀孕妇女(I组)血清中的FGF,sICAM-1和SCF浓度为8.5 +/- 1.5 pg / mL,235.8 +/- 81.1 ng / mL和597.7 +/- 139.9 pg / mL,未注射的女性相应浓度(第二组)分别为6.4 +/- 3.6 pg / mL,230.6 +/- 66.5 ng / mL和569.6 +/- 91.4 pg / mL,差异无统计学意义。在两组中观察到关于控制性卵巢过度刺激使用的hMG安瓿的数量,人绒毛膜促性腺激素(hCG)注射当天的雌二醇浓度,回收的卵母细胞数量和受精率。结论:两组血清或FF中FGF,sICAM-1和SCF的浓度无明显差异。此外,ICSI结局与其血清或FF中的浓度无关。因此,这些参数不能用作ICSI程序中的预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号